Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Risk of Cancer Mortality according to the Metabolic Health Status and Degree of Obesity

  • Oh, Chang-Mo (National Cancer Control Institute, National Cancer Center) ;
  • Jun, Jae Kwan (National Cancer Control Institute, National Cancer Center) ;
  • Suh, Mina (National Cancer Control Institute, National Cancer Center)
  • Published : 2014.12.18
Download PDF
⟨ Previous Next ⟩

Abstract

Background: We investigated the risk of cancer mortality according to obesity status and metabolic health status using sampled cohort data from the National Health Insurance system. Materials and Methods: Data on body mass index and fasting blood glucose in the sampled cohort database (n=363,881) were used to estimate risk of cancer mortality. Data were analyzed using a Cox proportional hazard model (Model 1 was adjusted for age, sex, systolic blood pressure, diastolic blood pressure, total cholesterol level and urinary protein; Model 2 was adjusted for Model 1 plus smoking status, alcohol intake and physical activity). Results: According to the obesity status, the mean hazard ratios were 0.82 [95% confidence interval (CI), 0.75-0.89] and 0.79 (95% CI, 0.72-0.85) for the overweight and obese groups, respectively, compared with the normal weight group. According to the metabolic health status, the mean hazard ratio was 1.26 (95% CI, 1.14-1.40) for the metabolically unhealthy group compared with the metabolically healthy group. The interaction between obesity status and metabolic health status on the risk of cancer mortality was not statistically significant (p=0.31). Conclusions: We found that the risk of cancer mortality decreased according to the obesity status and increased according to the metabolic health status. Given the rise in the rate of metabolic dysfunction, the mortality from cancer is also likely to rise. Treatment strategies targeting metabolic dysfunction may lead to reductions in the risk of death from cancer.

Keywords

References

  1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999). Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med, 341, 1097-105. https://doi.org/10.1056/NEJM199910073411501
  2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38. https://doi.org/10.1056/NEJMoa021423
  3. Dahlberg SE, Schiller JH, Bonomi PB, et al (2013). Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern cooperative oncology group clinical trials. J Thorac Oncol, 8, 1121-7. https://doi.org/10.1097/JTO.0b013e31829cf942
  4. Finkelstein EA, Khavjou OA, Thompson H, et al. (2012) Obesity and severe obesity forecasts through 2030. Am J Prev Med, 42, 563-70. https://doi.org/10.1016/j.amepre.2011.10.026
  5. Flegal KM, Kit BK, Orpana H, Graubard BI (2013). Association of all-cause mortality with overweight and obesity using standard body mass index categories. JAMA, 309, 71-82. https://doi.org/10.1001/jama.2012.113905
  6. Garcia-Jimenez C, Garcia-Martinez JM, Chocarro-Calvo A, De la Vieja A (2013). A new link between diabetes and cancer: enhanced WNT/$\beta$-catenin signaling by high glucose. J Mol Endocrinol, 52, 51-66. https://doi.org/10.1530/JME-13-0152
  7. Gambhir SS (2002). Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer, 2, 683-93. https://doi.org/10.1038/nrc882
  8. Giovannucci E, Harlan DM, Archer MC, et al. (2010). Diabetes and cancer: a consensus report. CA Cancer J Clin, 60, 207-21. https://doi.org/10.3322/caac.20078
  9. Jee SH, Sull JW, Park J, et al (2006). Body-mass index and mortality in Korean men and women. N Engl J Med, 355, 779-87. https://doi.org/10.1056/NEJMoa054017
  10. Jung KW, Won YJ, Kong HJ, et al (2014). Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2011. Cancer Res Treat, 46, 109-23. https://doi.org/10.4143/crt.2014.46.2.109
  11. Kang HT, Shim JY, Lee HR, et al (2014). Trends in prevalence of overweight and obesity in Korean adults, 1998-2009: the Korean national health and nutrition examination survey. J Epidemiol, 24, 109-16. https://doi.org/10.2188/jea.JE20130017
  12. Lee SR, Cha MJ, Kang DY, et al (2013). Increased prevalence of metabolic syndrome among hypertensive population. International J Cardiology, 166, 633-9. https://doi.org/10.1016/j.ijcard.2011.11.095
  13. Lee KS, Park JH (2013). Burden of disease in Korea during 2000-10. J Public Health (Oxf), 36, 225-34.
  14. Lee JY, Park NH, Song YS, et al (2013). Prevalence of the metabolic syndrome and associated factors in Korean cancer survivors. Asian Pac J Cancer Prev, 14, 1773-80. https://doi.org/10.7314/APJCP.2013.14.3.1773
  15. Liu H, Ma Q, Li J (2011). High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol Cell Biochem, 347, 95-101. https://doi.org/10.1007/s11010-010-0617-0
  16. McGee DL, Diverse Populations Collaboration (2005). Body mass index and mortality: a meta-analysis based on personlevel data from twenty-six observational studies. Ann Epidemiol, 15, 87-97. https://doi.org/10.1016/j.annepidem.2004.05.012
  17. Moore LL, Bradlee ML, Singer MR, et al (2004). BMI and waist circumference as predictors of lifetime colon cancer risk in framingham study adults. Int J Obes Relat Metab Disord, 28, 559-67. https://doi.org/10.1038/sj.ijo.0802606
  18. Moore LL, Chadid S, Singer MR, Kreger BE, Denis GV (2014). Metabolic health reduces risk of obesity-related cancer in Framingham study adults. Cancer Epidemiol Biomerkers Prev, 23, 1-9.
  19. Morrison DS, Parr CL, Lam TH, et al (2013). Colon and rectum cancer: analysis of data from the Asia-Pacific cohort studies collaboration. Asian Pac J Cancer Prev, 14, 1083-7. https://doi.org/10.7314/APJCP.2013.14.2.1083
  20. Nunez NP, Oh WJ, Rozenberg J, et al (2006). Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res, 66, 5469-76. https://doi.org/10.1158/0008-5472.CAN-05-4102
  21. Ozbek E, Otunctemur A, Sahin S, et al (2013). Renal cell carcinoma is more aggressive in Turkish patients with the metabolic syndrome. Asian Pac J Cancer Prev, 14, 7351-4. https://doi.org/10.7314/APJCP.2013.14.12.7351
  22. Parekh N, Lin Y, Vadiveloo M, Hayes RB, Lu-Yao GL (2013). Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart studyoffspring cohort (1971-2008). Cancer Epidemiol Biomerkers Prev, 22, 1825-36. https://doi.org/10.1158/1055-9965.EPI-13-0330
  23. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-78. https://doi.org/10.1016/S0140-6736(08)60269-X
  24. Seidell JC, Verschuren WM, van Leer EM, Kromhout D (1996). Overweight, underweight, and mortality. A prospective study of 48, 287 men and women. Arch Intern Med, 156, 958-63. https://doi.org/10.1001/archinte.1996.00440090054006
  25. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2014 [cited 2014 Sep 24]. Available from: http://kosis. kr.
  26. Stattin P, Bjor O, Ferrari P, et al (2007). Prospective study of hyperglycemia and cancer risk. Diabetes Care, 30, 561-7. https://doi.org/10.2337/dc06-0922
  27. Uzel EK, Ekmekcioglu O, Elicin O, Halac M, Uzel OE (2013). Is FDG-PET-CT a valuable tool in prediction of persistent disease in head and neck cancer. Asian Pac J Cancer Prev, 14, 4847-51. https://doi.org/10.7314/APJCP.2013.14.8.4847
  28. Vucenik I, Stains JP (2012). Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci, 1271, 37-43. https://doi.org/10.1111/j.1749-6632.2012.06750.x
  29. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. (2008) Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring), 16, 2323-30. https://doi.org/10.1038/oby.2008.351
  30. World Health Organization (1994). International statistical classification of diseases and related health problems, 10th rev. Geneva: World Health Organization.
  31. World Health Organization (2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser, 894, 1-253.

Cited by

  1. Village Voices: Lessons about Processes for Disease Prevention from a Qualitative Study of Family Health Leaders in a Community in Northeastern Thailand vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4401
  2. Laparoscopic Retroperitoneal Nephroureterectomy is a Safe and Adherent Modality for Obese Patients with Upper Urinary Tract Urothelial Carcinoma vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3223
  3. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer vol.34, pp.30, 2016, https://doi.org/10.1200/JCO.2016.67.4473
  4. The association between metabolic health, obesity phenotype and the risk of breast cancer vol.140, pp.12, 2017, https://doi.org/10.1002/ijc.30684
  5. A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality pp.19307381, 2017, https://doi.org/10.1002/oby.22067